Topics Subscribe to this feed

Cancer

Esophageal Cancer “Cell of Origin” Identified

October 11, 2017

Columbia researchers have identified cells that give rise to Barrett’s esophagus, a precursor to esophageal cancer, the fastest-growing cancer in the United States.

Urine Test Improves Prediction of High-Grade Prostate Cancer

An experimental urine test that detects genetic changes associated with prostate cancer identified 92 percent of men with elevated PSA levels who had more aggressive disease.

Immunotherapy: Cancer’s Newest Frontier

A Super Bowl ad has launched a new campaign at NewYork-Presbyterian Hospital that showcases Columbia and Weill Cornell expertise in cancer, particularly immunotherapy.

New Way to Identify Brain Tumor Aggressiveness

A comprehensive analysis of the molecular characteristics of gliomas—the most common malignant brain tumor—explains why some patients diagnosed with slow-growing (low-grade) tumors quickly succumb to the disease while others with more aggressive (high-grade) tumors survive for many years.

National Cancer Centers Endorse HPV Vaccination for Cancer Prevention

NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine are among the nation’s top cancer centers calling for increased human papillomavirus (HPV) vaccination for the prevention of cancer.

Biomarker Predicts Which Stage II Colon Cancer Patients May Benefit from Chemotherapy

Researchers have identified a biomarker that predicts which stage II colon cancer patients may benefit from adjuvant chemotherapy to prevent a disease recurrence.

Columbia University Medical Center Newsroom

Schools

For Faculty and Staff

Topics

For the Media

Cancer

Esophageal Cancer “Cell of Origin” Identified

RESEARCH

EDUCATION

PATIENT CARE

ABOUT US

NEWSROOM